Guilty plea for counterfeit drug packaging

Published on May 31, 2017
information-circle This article is more than 3 years old

The CEO of a packaging company has entered a guilty plea to a charge he made counterfeit labels and packaging for veterinary drugs.

Paul S. Rodriguez, CEO of Action Packaging & Design of Santa Ana, California, had been accused of making the imitation labels, boxes, and documentation for Frontline and Frontline Plus, which are flea and tick control products from Merial, and labels for Rimadyl, a nonsteroidal anti-inflammatory drug from Zoetis. He is scheduled for sentencing Oct. 2.

He was accused of shipping the labels, documentation, and packaging he made to a location in Houston. Assistant U.S. Attorney Daniel Rodriguez said in court that Paul Rodriguez was the subject of an undercover investigation, and he had sent the counterfeit materials to a warehouse operated by the Department of Homeland Security, according to information provided by Angela Dodge, spokeswoman for the U.S. Attorney’s Office in the Southern District of Texas.

No information about the basis for the undercover investigation was available at press time.